ResearcherThe University of TokyoNo recent work listed

Tomoki Todo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0523-8010; OpenAlex author ID A5046264170. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors. Last author DOI 10.1016/j.omto.2022.12.001 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tomoharu Yamada · 1 shared paper, 2023 · strength 0.19
- Paper Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immu… DOI 10.1016/j.omto.2022.12.001 ↗
Makoto Sano · 1 shared paper, 2023 · strength 0.19
- Paper Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immu… DOI 10.1016/j.omto.2022.12.001 ↗
Kazuhiko Koike · 1 shared paper, 2023 · strength 0.19
- Paper Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immu… DOI 10.1016/j.omto.2022.12.001 ↗
Hideaki Ijichi · 1 shared paper, 2023 · strength 0.19
- Paper Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immu… DOI 10.1016/j.omto.2022.12.001 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.